European Journal of Dermatology
MENUPsoriasis pharmacogenetics: HLA-Cw*0602 as a marker of therapeutic response to ustekinumab Volume 27, numéro 5, September-October 2017
Citer cet article
Citation de l'article, à la forme « Vancouver » :
Inês Raposo, Cláudia Carvalho, Andreia Bettencourt, Berta Martins Da Silva, Luiz Leite, Manuela Selores, Tiago Torres. Psoriasis pharmacogenetics: HLA-Cw*0602 as a marker of therapeutic response to ustekinumab. European Journal of Dermatology. 2017;27(5):528-530. doi:10.1684/ejd.2017.3071